用点数分配法识别抑郁症认知行为治疗试验中真正重要的结局
该研究采用在线点数分配法调查229名利益相关者(57名症状轻微者、108名现症患者、64名临床医生),对两项英国认知行为治疗试验的结局域进行优先级排序。结果显示三组对抑郁症状、生活质量、焦虑症状和活动影响的重视程度相似,但生活质量等结局在试验中极少测量,提示试验设计应纳入利益相关者重视的结局。
要点
- 利益相关者对抑郁症状、生活质量、焦虑症状和活动影响的重视程度相似。
- 生活质量等利益相关者重视的结局在抑郁症试验中极少测量。
- 年龄是现症患者组内结局域重要性的预测因素。
核心结论
- 利益相关者均衡重视多个结局域,抑郁症状并非唯一重要结局,生活质量等应纳入试验设计。
研究设计与样本
- 在线调查采用新型点数分配法,纳入229名利益相关者:57名症状轻微者(BDI-II≤18)、108名现症患者(BDI-II≥19)和64名临床医生。
主要发现
- 三组参与者对抑郁症状、生活质量、焦虑症状和活动影响的中位数点数分配相似。
- 社会人口学因素显著预测现症患者组内结局域重要性,年龄在该组内及跨组均为预测因素。
- 对点数分配的自由文本解释进行了主题分析。
关键数值与推荐
- 症状轻微者定义为贝克抑郁量表第二版(BDI-II)评分≤18,现症患者定义为BDI-II评分≥19。
临床怎么用
- 临床试验设计应纳入利益相关者重视的结局,可考虑采用利益相关者加权复合结局捕捉更广泛的获益判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Depression trials typically use symptom-based outcomes to determine treatment efficacy. Qualitative work with service users and clinicians indicates that other outcomes may be equally or more important. Quantitative investigations are needed to assess the relative importance of outcomes to key stakeholders. AIMS: To examine how stakeholders (service users with minimal symptoms (Beck Depression Inventory Second Edition (BDI-II) score ≤18), those who were currently symptomatic (BDI-II score ≥19) and clinicians working with people with depression) prioritise outcome domains drawn from two completed trials of cognitive behavioural therapy (CBT) for depression. This was from a new sample of stakeholders in order to explore similarities, differences and predictors of domain importance. METHOD: An online survey using a novel point-allocation method examined stakeholder priorities for outcome domains from two completed UK trials of CBT for depression. Stakeholder free-text responses explaining point allocations were thematically analysed. Multivariate analysis of covariance explored differences in domain importance across groups, and exploratory multivariate general linear models investigated predictive variables. RESULTS: In total, 229 participants completed the survey (57 with minimal symptoms, 108 who were currently symptomatic and 64 clinicians). Median point allocations suggest that all three participant groups assigned similar importance to depression symptoms, quality of life, anxiety symptoms and impact on activities. Sociodemographic factors significantly predicted domain importance within the currently symptomatic group, and age was a predictor both across and within this subgroup. CONCLUSIONS: Stakeholders valued several outcome domains with similar importance. While depression symptoms are not unimportant to stakeholders, they are balanced with other outcomes, such as quality of life, that are rarely measured in depression trials. These findings demonstrate the need to incorporate stakeholder-important outcomes into trial design, with stakeholder-weighted composite outcomes offering a potential method to capture this broader judgement of benefit.
引用
- Molloy N, Fabian H, Madigan A, et al. Using point allocation to identify outcomes that matter: results from two cognitive behavioural therapy trials for depression. Br J Psychiatry. 2026. PMID: 42755350. doi:10.1192/bjp.2026.10765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。